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Acetaminophen attenuates 
rhabdomyolysis- induced renal failure
Boutaud et al., Proc Natl Acad Sci USA 2010; 107: 2699–2704; doi:10.1073/
pnas.0910174107
Release of myoglobin or hemoglobin into the circulation due to 
muscle injury or hemolysis can cause multiple problems, includ-
ing renal failure. When these hemoproteins are released from the 
reducing environment of cells, the ferrous heme can be oxidized to 
the ferric state, conferring peroxidase activity to the hemoproteins. 
Consequently, hemoproteins can reduce hydroperoxides, such as 
hydrogen peroxide and lipid hydroperoxides, in a process that 
further oxidizes the hemoprotein to the ferryl state. Indeed, previ-
ous work suggests that generation of radical species by the heme 
redox cycling between ferric and ferryl states is responsible for the 
lipid peroxidation, and thus, the oxidative injuries associated with 
rhabdomyolysis, subarachnoid hemorrhage, and hemolysis. The 
coupling of a peroxidase-generated radical to lipid oxidation also 
occurs in the prostaglandin H2 synthases (PGHSs) that catalyze 
oxygenation of arachidonic acid. Acetaminophen inhibits PGHSs 
by blocking formation of the catalytic tyrosyl radical. The analogy 
between the peroxidase catalytic cycle of PGHSs and the pseu-
doperoxidase activity of myoglobin and hemoglobin led Boutaud 
et al. to postulate that acetaminophen could prevent the peroxida-
tion by these hemoproteins. They first demonstrated in vitro that 
acetaminophen inhibited hemoprotein-induced lipid peroxidation 
by reducing ferryl heme to its ferric state and quenching globin 
radicals. Heme-to-protein cross-linking is a more cytotoxic form of 
myoglobin that is generated at low pH, and in vitro, they also found 
that acetaminophen prevented both oxidative modifications and 
myoglobin cross-linking. More importantly, when rhabdomyolysis 
was induced in rats, pretreatment with acetaminophen so that the 
plasma concentrations were within the therapeutic range resulted 
in marked reduction of lipid peroxidation and improved kidney 
function, as shown in the concentration of plasma creatinine and 
the visual examination of the kidneys (Figure).
Thus, acetaminophen at therapeutic plasma concentrations sig-
nificantly decreased oxidant injury in the kidney, improved renal 
function, and reduced renal damage after rhabdomyolysis. In 
addition, the study suggests other potential therapeutic applications 
for acetaminophen in diseases involving hemoprotein-mediated 
oxidative injury.
Juan Oliver
Macrophage Wnt7b is critical  
for kidney repair
Lin et al., Proc Natl Acad Sci USA 2010; 107: 4194–4199; doi:10.1073/
pnas.0912228107
A substantial body of literature on several organs indicates that 
macrophages are important regulators of repair from injury. Wnt 
ligands and their receptors are also involved in tissue repair, and 
Wnt from macrophages was found to contribute to organogenesis. 
Lin et al. examined whether the canonical Wnt pathway was acti-
vated during kidney injury, and if so, whether it played a role in 
repair and regeneration. They induced transient ischemic injury 
in the kidneys of Wnt pathway reporter mice and found that there 
was marked upregulation of the Wnt pathway response 5 days after 
injury. Interestingly, this response was limited to interstitial cells and 
epithelial cells but not macrophages. To determine which molecular 
components of the Wnt pathway may be involved in the response 
to injury, the authors examined control and injured kidneys for 
mRNAs of ligands (Wnts), receptors (Fzds), and coreceptors (Lrp5 
and Lrp6) and learned that several ligands (Wnt2, 2b, 4, 5a, 7b, 10a) 
were upregulated. By isolating proximal tubular cells and renal mac-
rophages, they found that macrophages were the likely source of 
Wnt ligands to which the epithelial cells responded and that Wnt7b 
was the likely critical ligand. To directly test whether macrophage 
Wnt ligands were involved in repair, they ablated macrophages in 
vivo and found that this caused a marked reduction of the activation 
of the Wnt pathway. To directly examine the role of Wnt7b from 
macrophages, they selectively deleted Wnt7b in these cells with Cre-
Lox technology. As shown in the Figure, this resulted in markedly 
retarded repair after injury.
Thus, these results indicate that repair of damaged kidney tubules 
is mediated by an influx of macrophages that produce Wnt7b and 
signal locally to intact kidney epithelial progenitors.
Juan Oliver
Deletion of Wnt7b in macrophages prevents normal repair and regeneration 
of the kidney following ischemia/reperfusion (I/R) injury. Quantification of 
tubular injury 7 days after transient ischemic injury in appropriate control 
mice (left and middle bars) and in mice with deletion of macrophage Wnt7b.
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(a) Effect of treatment with acetaminophen on plasma creatinine during 
rhabdomyolysis. (b) Visual examination of a representative kidney from 
a normal rat (left), a rat with rhabdomyolysis (middle), and a rat with 
rhabdomyolysis treated with acetaminophen (ApAP) (right). 
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Genetic background modulation  
of the kidney’s response to UUO
Puri et al., Am J Physiol Renal Physiol 2010; 298: F1024–F1032; doi:10.1152/
ajprenal.00384.2009
Although the kidney has a remarkable capacity to recover from 
injury, many kidney diseases inexorably progress to end-stage renal 
disease. The morphological hallmark under these conditions is the 
progressive substitution of the normal renal parenchyma by fibrotic 
tissue. Hence, the mechanisms responsible for renal fibrosis gener-
ate great interest.
The unilateral ureteral obstruction (UUO) model has been widely 
used to study renal fibrosis, as it offers several advantages over bilat-
eral renal diseases, and it can be used in a transient manner, thus 
allowing analysis of renal repair from injury. In a recent publica-
tion, Puri et al. examined whether the genetic background of mouse 
strains frequently used in the laboratory affected the response of 
their kidneys to transient UUO. They used a reversible UUO model 
in C57BL/6 and BALB/c strains. They found that UUO of only 3 
days’ duration caused chronic kidney disease (assayed by blood urea 
nitrogen) in C57BL/6, but in marked contrast, BALB/c mice were 
resistant to development of chronic kidney disease with up to 10 
days of UUO. Analysis of the histological features of a 6-day revers-
ible UUO episode at various times (Figure) showed that at day 0 (6 
days of UUO), as expected, there was considerable tubular injury 
with tubular dilatation, epithelial-cell flattening, and loss of brush 
border. In addition, interstitial inflammation was readily apparent 
and somewhat more prominent in kidneys from the C57BL/6 mice. 
However, at 7 days of post-reversible UUO, C57BL/6 mice had fur-
ther inflammation, tubular atrophy, and interstitial fibrosis, whereas 
in BALB/c mice there was a gradual return toward normal histol-
ogy. Histological differences were apparent up to 28 days of post-
reversible UUO, with C57BL/6 mouse kidneys displaying persistent 
mild interstitial inflammation associated with patchy areas of inter-
stitial fibrosis around atrophic tubules, whereas BALB/c kidneys 
had a normal histological appearance.
These findings highlight the importance of the genetic back-
ground in analysis of the kidney’s response to UUO and provide 
an exciting model to investigate the genetic basis of the kidney’s 
recovery from transient UUO.
Juan Oliver
Autophagy influences glomerular 
disease susceptibility and maintains 
podocyte homeostasis in aging mice
Hartleben et al., J Clin Invest 2010; 120: 1084–1096; doi:10.1172/JCI39492
Autophagy is increasingly being recognized as a mechanism to con-
trol cellular homeostasis under a large variety of stress situations. 
Autophagy is a pathway for removing cytosolic and membrane-
associated proteins as well as entire cell organelles in an attempt 
to salvage cellular proteins during starvation and other types of 
tissue stress. As such, autophagy has been recognized to play a sig-
nificant role in neurodegenerative as well as cardiac and liver dis-
eases. In the kidney, increased autophagy has been shown during 
ischemia/reperfusion injury, transplant ischemia, and cisplatinum 
and cyclosporine toxicity. In response to the associated cellular 
and tissue stress, autophagy is induced and may either serve as a 
cell survival mechanism or contribute to cell death. Hartleben et 
al. examined the potential role of autophagy in the function and 
survival of podocytes, as injury and loss of podocytes are leading 
factors of glomerular disease and renal failure. They report that 
podocytes exhibit an unusually high level of constitutive autophagy. 
Podocyte-specific deletion of autophagy-related gene 5 (Atg5) led 
to a glomerulopathy in aging mice that was accompanied by an 
accumulation of oxidized and ubiquitinated proteins, endoplas-
mic reticulum stress, and proteinuria. These changes resulted ulti-
mately in podocyte loss and late-onset glomerulosclerosis. Analysis 
of pathophysiological conditions indicated that autophagy was 
substantially increased in glomeruli from mice with induced pro-
teinuria and in glomeruli from patients with acquired proteinuric 
diseases. Further, mice lacking Atg5 in podocytes exhibited strongly 
increased susceptibility to models of glomerular disease.
These findings highlight the importance of induced autophagy 
as a key homeostatic mechanism to maintain podocyte integrity. 
On the basis of these data, the authors postulate that constitutive 
and induced autophagy is a major protective mechanism against 
podocyte aging and glomerular injury. In addition, these results 
may shed some light on how sirolimus, an inhibitor of mTOR, may 
have beneficial effects in some glomerular diseases that are inde-
pendent of the immune suppression. Sirolimus activates autophagy 
by inhibiting the kinase activity of mTOR, an effect that is inde-
pendent of the immune suppression. If some of the beneficial effects 
of sirolimus turn out to be due to activation of autophagy, this 
mechanism may represent a putative target to ameliorate human 
glomerular disease and aging-related loss of renal function.
Detlef Schlondorff
Representative hematoxylin- and eosin-stained sections from C57BL/6 
and BALB/c mice at various times following release of 6 days of right ureter 
obstruction (RUOR).
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